Condition
CRBSI - Catheter Related Bloodstream Infection
Total Trials
7
Recruiting
1
Active
2
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 2 (1)
Trial Status
Completed4
Not Yet Recruiting1
Active Not Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT05813535Phase 2Completed
8.4% Sodium Bicarbonate Locks in Intestinal Failure
NCT07585188Not ApplicableNot Yet Recruiting
Neonatal Catheter Lock for Infection Prevention
NCT06604026Not ApplicableCompletedPrimary
Investigational Study With the BD PosiFlush™ SafeScrub on NADs
NCT06085690Not ApplicableRecruitingPrimary
Multicenter Clinical Translational Study of "ICU-NO CRBSI" Based on Improvement Science
NCT07138690CompletedPrimary
Complications and Failure of Centrally Inserted Central Catheters in Cardiac Surgical Patients
NCT06566495Active Not Recruiting
Microorganisms on Reusable Tourniquets
NCT04927325Not ApplicableCompleted
Erythema at Exit Site & Tablet Camera
Showing all 7 trials